Valuation: Virbac

Market Cap 2.58B 2.93B 2.44B 2.21B 4.15B 281B 4.18B 29.18B 11.27B 144B 11B 10.76B 461B P/E 2026 *
14.9x
P/E 2027 * 13.4x
Enterprise Value 2.7B 3.07B 2.55B 2.32B 4.35B 295B 4.37B 30.57B 11.81B 150B 11.52B 11.28B 483B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.59x
Free-Float
49.03%
Yield 2026 *
0.56%
Yield 2027 * 0.66%
1 day+1.63%
1 week+1.63%
Current month-3.10%
1 month-3.10%
3 months-7.82%
6 months-11.35%
Current year-12.59%
1 week 301
Extreme 301
314
1 month 297
Extreme 297
326
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 249.7
Extreme 249.7
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap. Importance
4/22/24 Sell

Chief Executive Officer

810 0.0096%
4/22/24 Sell

Chief Executive Officer

140 0.0017%
4/22/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+1.63%+1.63%-0.48%+22.07% 2.93B
+0.53%+0.14%-50.22%-58.95% 29.52B
+0.63%+0.09%+14.48%+100.63% 11.22B
-0.25%-5.73%-14.35%-2.30% 3.7B
+0.83%+2.40%+27.01%+52.06% 1.93B
+0.09%-2.48%+22.16%+21.25% 1.85B
+3.63%+2.94%-8.01%+187.21% 1.45B
-0.66%-3.55%-20.93%-9.46% 1.12B
+0.45%-1.62%-5.52%-40.92% 1.01B
+3.22%+1.85%+0.65%-1.28% 986M
Average +0.93%-0.90%-3.52%+27.03% 5.57B
Weighted average by Cap. +0.21%-0.35%-23.71%-3.54%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.46B 1.33B 2.49B 169B 2.51B 17.52B 6.77B 86.17B 6.6B 6.46B 277B 1.64B 1.87B 1.55B 1.41B 2.65B 179B 2.66B 18.62B 7.19B 91.58B 7.02B 6.87B 294B
Net income 174M 198M 164M 149M 280M 18.98B 282M 1.97B 760M 9.69B 742M 726M 31.12B 194M 220M 183M 166M 312M 21.14B 314M 2.19B 847M 10.79B 827M 809M 34.67B
Net Debt 122M 139M 116M 105M 197M 13.36B 198M 1.39B 535M 6.82B 522M 511M 21.91B 44.72M 50.85M 42.29M 38.36M 72.03M 4.88B 72.45M 506M 196M 2.49B 191M 187M 8B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-09-29 €312.50 +1.63% 1,189
26-09-28 €307.50 +1.32% 5,029
26-09-25 €303.50 +0.50% 4,384
26-09-24 €302.00 -0.82% 4,422
26-09-23 €304.50 -0.98% 6,681
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
307.50EUR
Average target price
412.75EUR
Spread / Average Target
+34.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock